Zahed Siddique

Prof. Zahed Siddique

University of Oklahoma
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2021 in Technologies
Verified
Journal Article
Open access
PDF file
MAMd Manjurul Ahsan
Md Manjurul Ahsan
MMM A Parvez Mahmud
M A Parvez Mahmud
PSPritom Kumar Saha
Pritom Kumar Saha
KGKishor Datta Gupta
Kishor Datta Gupta
ZSZahed Siddique
Zahed Siddique
Heart disease, one of the main reasons behind the high mortality rate around the world, requires a sophisticated and expensive diagnosis process. In the recent past, much literature has demonstrated machine learning approaches as an opportunity to efficiently diagnose heart disease patients. However, challenges associated with datasets such as missing data, inconsistent data, and mixed data (containing inconsistent missing data both as numerical and categorical) are often obstacles in medical diagnosis. This inconsistency led to a higher probability of misprediction and a misled result. Data preprocessing steps like feature reduction, data conversion, and data scaling are employed to form a standard dataset—such measures play a crucial role in reducing inaccuracy in final prediction. This paper aims to evaluate eleven machine learning (ML) algorithms—Logistic Regression (LR), Linear Discriminant Analysis (LDA), K-Nearest Neighbors (KNN), Classification and Regression Trees (CART), Naive Bayes (NB), Support Vector Machine (SVM), XGBoost (XGB), Random Forest Classifier (RF), Gradient Boost (GB), AdaBoost (AB), Extra Tree Classifier (ET)—and six different data scaling methods—Normalization (NR), Standscale (SS), MinMax (MM), MaxAbs (MA), Robust Scaler (RS), and Quantile Transformer (QT) on a dataset comprising of information of patients with heart disease. The result shows that CART, along with RS or QT, outperforms all other ML algorithms with 100% accuracy, 100% precision, 99% recall, and 100% F1 score. The study outcomes demonstrate that the model’s performance varies depending on the data scaling method.

15 March 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
MAMd Manjurul Ahsan
Md Manjurul Ahsan
SLShahana Akter Luna
Shahana Akter Luna
ZSZahed Siddique
Zahed Siddique
Globally, there is a substantial unmet need to diagnose various diseases effectively. The complexity of the different disease mechanisms and underlying symptoms of the patient population presents massive challenges in developing the early diagnosis tool and effective treatment. Machine learning (ML), an area of artificial intelligence (AI), enables researchers, physicians, and patients to solve some of these issues. Based on relevant research, this review explains how machine learning (ML) is being used to help in the early identification of numerous diseases. Initially, a bibliometric analysis of the publication is carried out using data from the Scopus and Web of Science (WOS) databases. The bibliometric study of 1216 publications was undertaken to determine the most prolific authors, nations, organizations, and most cited articles. The review then summarizes the most recent trends and approaches in machine-learning-based disease diagnosis (MLBDD), considering the following factors: algorithm, disease types, data type, application, and evaluation metrics. Finally, in this paper, we highlight key results and provides insight into future trends and opportunities in the MLBDD area.

30 March 2022 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
MAMd Manjurul Ahsan
Md Manjurul Ahsan
ZSZahed Siddique
Zahed Siddique

13 October 2023 in Materials
Verified
Journal Article
Open access
PDF file
MAMd Tanvir Ahad
Md Tanvir Ahad
MBMd Monjur Hossain Bhuiyan
Md Monjur Hossain Bhuiyan
Ahmed Nazmus SakibAhmed Nazmus Sakib
Ahmed Nazmus Sakib
ACAlfredo Becerril Corral
Alfredo Becerril Corral
ZSZahed Siddique
Zahed Siddique
Hydrogen’s wide availability and versatile production methods establish it as a primary green energy source, driving substantial interest among the public, industry, and governments due to its future fuel potential. Notable investment is directed toward hydrogen research and material innovation for transmission, storage, fuel cells, and sensors. Ensuring safe and dependable hydrogen facilities is paramount, given the challenges in accident control. Addressing material compatibility issues within hydrogen systems remains a critical focus. Challenges, roadmaps, and scenarios steer long-term planning and technology outlooks. Strategic visions align actions and policies, encompassing societal and ecological dimensions. The confluence of hydrogen’s promise with material progress holds the prospect of reshaping our energy landscape sustainably. Forming collective future perspectives to foresee this emerging technology’s potential benefits is valuable. Our review article comprehensively explores the forthcoming challenges in hydrogen technology. We extensively examine the challenges and opportunities associated with hydrogen production, incorporating CO2 capture technology. Furthermore, the interaction of materials and composites with hydrogen, particularly in the context of hydrogen transmission, pipeline, and infrastructure, are discussed to understand the interplay between materials and hydrogen dynamics. Additionally, the exploration extends to the embrittlement phenomena during storage and transmission, coupled with a comprehensive examination of the advancements and hurdles intrinsic to hydrogen fuel cells. Finally, our exploration encompasses addressing hydrogen safety from an industrial perspective. By illuminating these dimensions, our article provides a panoramic view of the evolving hydrogen landscape.

25 August 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
MAMd Manjurul Ahsan
Md Manjurul Ahsan
RNRedwan Nazim
Redwan Nazim
ZSZahed Siddique
Zahed Siddique
PHPedro Huebner
Pedro Huebner
The COVID-19 global pandemic caused by the widespread transmission of the novel coronavirus (SARS-CoV-2) has become one of modern history’s most challenging issues from a healthcare perspective. At its dawn, still without a vaccine, contagion containment strategies remained most effective in preventing the disease’s spread. Patient isolation has been primarily driven by the results of polymerase chain reaction (PCR) testing, but its initial reach was challenged by low availability and high cost, especially in developing countries. As a means of taking advantage of a preexisting infrastructure for respiratory disease diagnosis, researchers have proposed COVID-19 patient screening based on the results of Chest Computerized Tomography (CT) and Chest Radiographs (X-ray). When paired with artificial-intelligence- and deep-learning-based approaches for analysis, early studies have achieved a comparatively high accuracy in diagnosing the disease. Considering the opportunity to further explore these methods, we implement six different Deep Convolutional Neural Networks (Deep CNN) models—VGG16, MobileNetV2, InceptionResNetV2, ResNet50, ResNet101, and VGG19—and use a mixed dataset of CT and X-ray images to classify COVID-19 patients. Preliminary results showed that a modified MobileNetV2 model performs best with an accuracy of 95 ± 1.12% (AUC = 0.816). Notably, a high performance was also observed for the VGG16 model, outperforming several previously proposed models with an accuracy of 98.5 ± 1.19% on the X-ray dataset. Our findings are supported by recent works in the academic literature, which also uphold the higher performance of MobileNetV2 when X-ray, CT, and their mixed datasets are considered. Lastly, we further explain the process of feature extraction using Local Interpretable Model-Agnostic Explanations (LIME), which contributes to a better understanding of what features in CT/X-ray images characterize the onset of COVID-19.

23 February 2021 in IEEE Access
Verified
Journal Article
Open access
MAMd Manjurul Ahsan
Md Manjurul Ahsan
MD TANVIR AHADMD TANVIR AHAD
MD TANVIR AHAD
FSFarzana Akter Soma
Farzana Akter Soma
Shuva PaulShuva Paul
Shuva Paul
ACAnanna Chowdhury
Ananna Chowdhury
PHPedro Huebner
Pedro Huebner
Chest radiographs (X-rays) combined with Deep Convolutional Neural Network (CNN) methods have been demonstrated to detect and diagnose the onset of COVID-19, the disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). However, questions remain regarding the accuracy of those methods as they are often challenged by limited datasets, performance legitimacy on imbalanced data, and have their results typically reported without proper confidence intervals. Considering the opportunity to address these issues, in this study, we propose and test six modified deep learning models, including VGG16, InceptionResNetV2, ResNet50, MobileNetV2, ResNet101, and VGG19 to detect SARS-CoV-2 infection from chest X-ray images. Results are evaluated in terms of accuracy, precision, recall, and f- score using a small and balanced dataset (Study One), and a larger and imbalanced dataset (Study Two). With 95% confidence interval, VGG16 and MobileNetV2 show that, on both datasets, the model could identify patients with COVID-19 symptoms with an accuracy of up to 100%. We also present a pilot test of VGG16 models on a multi-class dataset, showing promising results by achieving 91% accuracy in detecting COVID-19, normal, and Pneumonia patients. Furthermore, we demonstrated that poorly performing models in Study One (ResNet50 and ResNet101) had their accuracy rise from 70% to 93% once trained with the comparatively larger dataset of Study Two. Still, models like InceptionResNetV2 and VGG19's demonstrated an accuracy of 97% on both datasets, which posits the effectiveness of our proposed methods, ultimately presenting a reasonable and accessible alternative to identify patients with COVID-19.